Insider · CIK 0001266125

BRISTOW MICHAEL R

Reports to the SEC for 2 companies · BROOMFIELD, CO

sec.gov

Transactions

Companies

Filings

CIK

0001266125

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-12-14	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+95K sh	—	—	95,000
2020-12-21	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+190K sh	—	—	190,000
2017-04-04	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−720 sh	$2.41	−$1,735.2	41,155
2017-02-28	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−763 sh	$2.61	−$1,991.43	41,875
2017-02-27	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+41.6K sh	—	—	41,600
2017-02-16	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+42K sh	—	—	42,000
2016-09-20	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−1,972 sh	$2.89	−$5,699.08	42,638
2016-06-09	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+55.4K sh	—	—	55,400
2016-06-09	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+27.2K sh	—	—	27,200
2016-04-05	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−724 sh	$3.52	−$2,548.48	44,610
2016-03-01	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−752 sh	$3.50	−$2,632	45,334
2015-09-18	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−1,809 sh	$6.33	−$11.5K	46,086
2015-03-02	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−5,446 sh	$0.71	−$3,883.543	335,279
2015-02-12	ORKAOruka Therapeutics, Inc.A Award	Director, Pres. & Chief Executive Offic	AAward	+48.1K sh	—	—	340,725
2015-02-12	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+25.9K sh	—	—	25,900
2014-09-18	ORKAOruka Therapeutics, Inc.S Sale	Director, Pres. & Chief Executive Offic	SSale	−13.9K sh	$1.30	−$18K	292,625
2014-02-27	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+51.5K sh	—	—	51,500
2014-02-27	ORKAOruka Therapeutics, Inc.A Award	Director, Pres. & Chief Executive Offic	AAward	+56.7K sh	$1.95	+$111K	306,478
2013-09-17	ORKAOruka Therapeutics, Inc.A Award	Director, Pres. & Chief Executive Offic	AAward	+125K sh	$1.38	+$173K	249,778
2013-09-17	ORKAOruka Therapeutics, Inc. · Stock Option (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+283K sh	—	—	282,825
2013-06-12	ORKAOruka Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director, Pres. & Chief Executive Offic	CConversion	−781 sh	$160.00	−$125K	0
2013-06-04	ORKAOruka Therapeutics, Inc. · Series A Convertible Preferred StockA Award	Director, Pres. & Chief Executive Offic	AAward	+781 sh	$160.00	+$125K	781
2013-06-04	ORKAOruka Therapeutics, Inc. · Common Stock Warrants (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+39.1K sh	—	—	39,050
2013-01-25	ORKAOruka Therapeutics, Inc. · Common stock warrants (right to buy)P Purchase	Director, Pres. & Chief Executive Offic	PPurchase	+749K sh	—	—	748,503
2013-01-25	ORKAOruka Therapeutics, Inc.P Purchase	Director, Pres. & Chief Executive Offic	PPurchase	+1.07M sh	$0.47	+$500K	1,069,290
2012-12-18	ORKAOruka Therapeutics, Inc.A Award	Director, Pres. & Chief Executive Offic	AAward	+517K sh	$0.48	+$250K	834,495
2012-12-18	ORKAOruka Therapeutics, Inc. · Common stock warrants (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+388K sh	—	—	387,837
2012-10-22	ORKAOruka Therapeutics, Inc.A Award	Director, Pres. & Chief Executive Offic	AAward	+317K sh	$0.39	+$125K	317,379
2012-10-22	ORKAOruka Therapeutics, Inc. · Common Stock Warrants (right to buy)A Award	Director, Pres. & Chief Executive Offic	AAward	+238K sh	—	—	238,024
2012-06-12	ORKAOruka Therapeutics, Inc.C Conversion	Director, Pres. & Chief Executive Offic	CConversion	+78.1K sh	—	—	124,778
2011-05-20	ORKAOruka Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, Pres. & Chief Executive Offic	AAward	−30K sh	—	—	30,000
2010-02-18	ORKAOruka Therapeutics, Inc. · Option to Purchase Common StockA Award	Director, Pres. & Chief Executive Offic	AAward	+16K sh	—	—	16,000
2009-10-14	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Director, Pres. & Chief Executive Offic	MExercise/Conversion	+7,394 sh	$0.06	+$443.64	280,071
2009-10-14	ORKAOruka Therapeutics, Inc. · Option to Purchase Common StockM Exercise/Conversion	Director, Pres. & Chief Executive Offic	MExercise/Conversion	−7,394 sh	—	—	0
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−2,500 sh	$30.07	−$75.2K	88,300
2006-01-03	MYOGEN INCM Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	+15K sh	$1.25	+$18.8K	90,800
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−2,500 sh	$30.07	−$75.2K	88,300
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−22.5K sh	$30.14	−$678K	65,800
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−5,000 sh	$30.03	−$150K	60,800
2006-01-03	MYOGEN INCStock Option (right to buy)M Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	−15K sh	—	—	60,000
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−22.5K sh	$30.14	−$678K	65,800
2006-01-03	MYOGEN INCStock Option (right to buy)M Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	−15K sh	—	—	60,000
2006-01-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−5,000 sh	$30.03	−$150K	60,800
2006-01-03	MYOGEN INCM Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	+15K sh	$1.25	+$18.8K	90,800
2005-12-21	MYOGEN INCJ Other	Director, Chief Science & Medical Off.	JOther	+21 sh	—	—	26,221
2005-10-03	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−10K sh	$23.66	−$237K	115,800
2005-10-03	MYOGEN INCStock Option (right to buy)M Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	−5,000 sh	—	—	115,000
2005-10-03	MYOGEN INCM Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	+5,000 sh	$1.25	+$6,250	125,800
2005-09-01	MYOGEN INCS Sale	Director, Chief Science & Medical Off.	SSale	−6,400 sh	$20.20	−$129K	120,800
2005-09-01	MYOGEN INCStock Option (right to buy)M Exercise/Conversion	Director, Chief Science & Medical Off.	MExercise/Conversion	−5,000 sh	—	—	0

Recent filings

Accepted (ET)
Dec 164
BRISTOW MICHAEL R0001209191-21-069960
SEC(opens sec.gov)
Dec 234
BRISTOW MICHAEL R0001209191-20-065002
SEC(opens sec.gov)
Apr 54
ARCA biopharma, Inc.0001209191-17-025617
SEC(opens sec.gov)
Mar 14
ARCA biopharma, Inc.0001209191-17-015978
SEC(opens sec.gov)
Feb 214
ARCA biopharma, Inc.0001209191-17-012757
SEC(opens sec.gov)
Sep 214
ARCA biopharma, Inc.0001209191-16-142261
SEC(opens sec.gov)
Jun 134
ARCA biopharma, Inc.0001209191-16-127439
SEC(opens sec.gov)
Apr 64
ARCA biopharma, Inc.0000899243-16-017729
SEC(opens sec.gov)
Mar 24
ARCA biopharma, Inc.0000899243-16-014985
SEC(opens sec.gov)
Sep 214
ARCA biopharma, Inc.0000899243-15-005097
SEC(opens sec.gov)
Mar 24
ARCA biopharma, Inc.0001209191-15-020302
SEC(opens sec.gov)
Feb 174
ARCA biopharma, Inc.0001209191-15-014713
SEC(opens sec.gov)
Sep 194
ARCA biopharma, Inc.0001209191-14-058829
SEC(opens sec.gov)
Mar 34
ARCA biopharma, Inc.0001209191-14-015845
SEC(opens sec.gov)
Sep 194
ARCA biopharma, Inc.0001209191-13-044978
SEC(opens sec.gov)

Companies

Address

C/O ARCA BIOPHARMA, INC. 8001 ARISTA PLACE, SUITE 200

BROOMFIELD, CO, 80021